The Key Players Global Prostate Cancer Devices Market 2015-2019, According to a New Study on ASDReports

Friday 26 June 2015, Amsterdam

Market Research Report Press Release

The report, now available on ASDReports, recognizes the following companies as the key players in the Global Prostate Cancer Devices Market: C. R. Bard, Elekta AB, Intuitive Surgical Inc., Siemens Healthcare, Theragenics Corp. and Varian Medical Systems

Other Prominent Vendors in the market are: Eckert & Ziegler BEBIG, EDAP TMS, Galil Medical, IsoRay, Philips Healthcare, Profound Medical and SonaCare Medical.

Commenting on the report, an analyst   said: “The increased adoption of robotic-assisted prostatectomy procedures is one of the major trends in the market. Use of robotic systems has increased the prognostics of patients, leading to increased adoption of prostate cancer treatment.”

According to the report, an increase in the aging population is the primary contributor to the growth of the market. It is projected that nearly 2 billion people will be aged 60 years and above by 2050. With aging, a person becomes more susceptible to several age-related disorders including urological disorders such as prostate cancer in men.

Further, the report states that complications associated with prostate cancer surgeries limits their adoption. Risks and side effects such as minor heart attacks, blood clots in the leg, and urinary incontinence hamper the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Global Prostate Cancer Devices Market 2015-2019

Global Prostate Cancer Devices Market 2015-2019

Publish date : June 2015
Report code : ASDR-206609
Pages : 91 Media contact: S. Koopman - Marketing and Communications / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E :

 back to News